These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 28690130)
1. Investigating the variation in the incidence of new Pseudomonas aeruginosa infection between paediatric cystic fibrosis centres. Gilchrist FJ; Jones AM; Smyth AR; Southern KW; Webb AK; Lenney W J Cyst Fibros; 2017 Sep; 16(5):e14-e16. PubMed ID: 28690130 [No Abstract] [Full Text] [Related]
2. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection. Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696 [TBL] [Abstract][Full Text] [Related]
3. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis? Pabary R; Huang J; Kumar S; Alton EW; Bush A; Hanna GB; Davies JC Eur Respir J; 2016 Mar; 47(3):994-7. PubMed ID: 26846826 [No Abstract] [Full Text] [Related]
4. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland. Logan C; Habington A; Lennon G; Grogan J; Byrne M; O'Leary J; O'Sullivan N J Med Microbiol; 2012 Jan; 61(Pt 1):64-70. PubMed ID: 21921114 [TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. Luna RA; Millecker LA; Webb CR; Mason SK; Whaley EM; Starke JR; Hiatt PW; Versalovic J J Clin Microbiol; 2013 Apr; 51(4):1237-40. PubMed ID: 23303498 [TBL] [Abstract][Full Text] [Related]
6. SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients. Lauridsen RK; Sommer LM; Johansen HK; Rindzevicius T; Molin S; Jelsbak L; Engelsen SB; Boisen A Sci Rep; 2017 Mar; 7():45264. PubMed ID: 28349938 [TBL] [Abstract][Full Text] [Related]
7. From molecules in space to molecules in breath. Smith D Paediatr Respir Rev; 2016 Jan; 17():50-2. PubMed ID: 26541224 [TBL] [Abstract][Full Text] [Related]
8. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Enderby B; Smith D; Carroll W; Lenney W Pediatr Pulmonol; 2009 Feb; 44(2):142-7. PubMed ID: 19148935 [TBL] [Abstract][Full Text] [Related]
9. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis. Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC; Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994 [TBL] [Abstract][Full Text] [Related]
10. The Approach to Pseudomonas aeruginosa in Cystic Fibrosis. Talwalkar JS; Murray TS Clin Chest Med; 2016 Mar; 37(1):69-81. PubMed ID: 26857769 [TBL] [Abstract][Full Text] [Related]
11. How reliable are cough swabs for the detection of Pseudomonas aeruginosa in adult patients with cystic fibrosis? Moore JE; McCaughan J; McNeilly J; Rendall JC; Downey DG Br J Biomed Sci; 2015; 72(4):206. PubMed ID: 26738405 [No Abstract] [Full Text] [Related]
12. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. Scott-Thomas AJ; Syhre M; Pattemore PK; Epton M; Laing R; Pearson J; Chambers ST BMC Pulm Med; 2010 Nov; 10():56. PubMed ID: 21054900 [TBL] [Abstract][Full Text] [Related]
13. Decisions facing the cystic fibrosis clinician at first isolation of Pseudomonas aeruginosa. Bush A Paediatr Respir Rev; 2002 Mar; 3(1):82-8. PubMed ID: 12065187 [TBL] [Abstract][Full Text] [Related]
14. Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis. Kotnik Pirš A; Krivec U; Simčič S; Seme K BMC Pulm Med; 2016 Nov; 16(1):161. PubMed ID: 27884144 [TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050 [TBL] [Abstract][Full Text] [Related]
16. An investigation of suitable bag materials for the collection and storage of breath samples containing hydrogen cyanide. Gilchrist FJ; Razavi C; Webb AK; Jones AM; Spaněl P; Smith D; Lenney W J Breath Res; 2012 Sep; 6(3):036004. PubMed ID: 22759377 [TBL] [Abstract][Full Text] [Related]
17. Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients. Hall AJ; Fothergill JL; McNamara PS; Southern KW; Winstanley C Diagn Microbiol Infect Dis; 2014 Dec; 80(4):324-6. PubMed ID: 25284374 [TBL] [Abstract][Full Text] [Related]
18. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy. Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750 [TBL] [Abstract][Full Text] [Related]
19. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. Smith D; Spaněl P; Gilchrist FJ; Lenney W J Breath Res; 2013 Dec; 7(4):044001. PubMed ID: 24287489 [TBL] [Abstract][Full Text] [Related]
20. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ranganathan SC; Skoric B; Ramsay KA; Carzino R; Gibson AM; Hart E; Harrison J; Bell SC; Kidd TJ; Ann Am Thorac Soc; 2013 Apr; 10(2):108-14. PubMed ID: 23607838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]